CABA
USDCabaletta Bio Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$2.860
고가
$2.970
저가
$2.630
거래량
3.67M
기업 기본 정보
시가총액
247.0M
산업
생명공학
국가
United States
거래 통계
평균 거래량
3.63M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety profile for autoimmune patients supporting outpatient use All myositis
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Cantor Fitzgerald Maintains Overweight on Cabaletta Bio, Raises Price Target to $30
Cantor Fitzgerald analyst Josh Schimmer maintains Cabaletta Bio with a Overweight and raises the price target from $15 to $30.
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS responses with no
관련 주식
EVAX
Evaxion Biotech A/S American Depositary Share
IPHA
Innate Pharma S.A. ADS
VSAC
Vision Sensing Acquisition Corp.
MFD
Macquarie First Trust Global
MGRB
Affiliated Managers Group Inc. 4.750% Junior Subordinated Notes due 2060
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기